BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12633763)

  • 21. Clinical relevance of kallikrein-related peptidase 6 (KLK6) and 8 (KLK8) mRNA expression in advanced serous ovarian cancer.
    Ahmed N; Dorn J; Napieralski R; Drecoll E; Kotzsch M; Goettig P; Zein E; Avril S; Kiechle M; Diamandis EP; Schmitt M; Magdolen V
    Biol Chem; 2016 Dec; 397(12):1265-1276. PubMed ID: 27483364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis.
    Yousef GM; Borgoño CA; Scorilas A; Ponzone R; Biglia N; Iskander L; Polymeris ME; Roagna R; Sismondi P; Diamandis EP
    Br J Cancer; 2002 Nov; 87(11):1287-93. PubMed ID: 12439719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer.
    Yousef GM; Scorilas A; Kyriakopoulou LG; Rendl L; Diamandis M; Ponzone R; Biglia N; Giai M; Roagna R; Sismondi P; Diamandis EP
    Clin Chem; 2002 Aug; 48(8):1241-50. PubMed ID: 12142380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients.
    Gong W; Liu Y; Seidl C; Dreyer T; Drecoll E; Kotzsch M; Bronger H; Dorn J; Magdolen V
    PLoS One; 2019; 14(2):e0212968. PubMed ID: 30811511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined expression of KLK4, KLK5, KLK6, and KLK7 by ovarian cancer cells leads to decreased adhesion and paclitaxel-induced chemoresistance.
    Loessner D; Quent VM; Kraemer J; Weber EC; Hutmacher DW; Magdolen V; Clements JA
    Gynecol Oncol; 2012 Dec; 127(3):569-78. PubMed ID: 22964375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma.
    Luo LY; Katsaros D; Scorilas A; Fracchioli S; Piccinno R; Rigault de la Longrais IA; Howarth DJ; Diamandis EP
    Clin Cancer Res; 2001 Aug; 7(8):2372-9. PubMed ID: 11489815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of kallikrein 10 in epithelial ovarian carcinomas.
    Shvartsman HS; Lu KH; Lee J; Lillie J; Deavers MT; Clifford S; Wolf JK; Mills GB; Bast RC; Gershenson DM; Schmandt R
    Gynecol Oncol; 2003 Jul; 90(1):44-50. PubMed ID: 12821340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.
    Talieri M; Mathioudaki K; Prezas P; Alexopoulou DK; Diamandis EP; Xynopoulos D; Ardavanis A; Arnogiannaki N; Scorilas A
    Thromb Haemost; 2009 Apr; 101(4):741-7. PubMed ID: 19350120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unfavorable prognostic value of human kallikrein 7 quantified by ELISA in ovarian cancer cytosols.
    Shan SJ; Scorilas A; Katsaros D; Rigault de la Longrais I; Massobrio M; Diamandis EP
    Clin Chem; 2006 Oct; 52(10):1879-86. PubMed ID: 16916986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer.
    Yousef GM; Scorilas A; Magklara A; Memari N; Ponzone R; Sismondi P; Biglia N; Abd Ellatif M; Diamandis EP
    Br J Cancer; 2002 Nov; 87(11):1294-300. PubMed ID: 12439720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.
    White NM; Mathews M; Yousef GM; Prizada A; Popadiuk C; Doré JJ
    Br J Cancer; 2009 Oct; 101(7):1107-13. PubMed ID: 19707197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer.
    Chang A; Yousef GM; Scorilas A; Grass L; Sismondi P; Ponzone R; Diamandis EP
    Br J Cancer; 2002 May; 86(9):1457-64. PubMed ID: 11986781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulated KLK13 expression in bladder cancer highlights tumor aggressiveness and unfavorable patients' prognosis.
    Tokas T; Avgeris M; Alamanis C; Scorilas A; Stravodimos KG; Constantinides CA
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):521-532. PubMed ID: 27858162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer.
    Yousef GM; Scorilas A; Nakamura T; Ellatif MA; Ponzone R; Biglia N; Maggiorotto F; Roagna R; Sismondi P; Diamandis EP
    Breast Cancer Res Treat; 2003 Mar; 78(2):149-58. PubMed ID: 12725415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kallikreins as markers of disseminated tumour cells in ovarian cancer-- a pilot study.
    Oikonomopoulou K; Scorilas A; Michael IP; Grass L; Soosaipillai A; Rosen B; Murphy J; Diamandis EP
    Tumour Biol; 2006; 27(2):104-14. PubMed ID: 16557045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer.
    Wang P; Magdolen V; Seidl C; Dorn J; Drecoll E; Kotzsch M; Yang F; Schmitt M; Schilling O; Rockstroh A; Clements JA; Loessner D
    Br J Cancer; 2018 Oct; 119(7):1-9. PubMed ID: 30287916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of multiple kallikreins in high-grade astrocytoma.
    Drucker KL; Gianinni C; Decker PA; Diamandis EP; Scarisbrick IA
    BMC Cancer; 2015 Aug; 15():565. PubMed ID: 26231762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer.
    Gong W; Liu Y; Seidl C; Diamandis EP; Kiechle M; Drecoll E; Kotzsch M; Magdolen V; Dorn J
    BMC Cancer; 2019 Jul; 19(1):696. PubMed ID: 31307411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma.
    Planque C; Li L; Zheng Y; Soosaipillai A; Reckamp K; Chia D; Diamandis EP; Goodglick L
    Clin Cancer Res; 2008 Mar; 14(5):1355-62. PubMed ID: 18316555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues.
    Yousef GM; Scorilas A; Chang A; Rendl L; Diamandis M; Jung K; Diamandis EP
    Prostate; 2002 May; 51(2):126-32. PubMed ID: 11948967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.